In these studies, it is not difficult to find that most of the progress of GBM resolution is achieved by regulating EGFR/PI3KAKT/ERK/NF-κB signaling, with NF-κB signaling mainly characterized by p65 phosphorylation, stability, and nuclear transport. The gene discussed is MAPK1; the disease is glioblastoma.